Potential direct anti-inflammatory mechanisms from preclinical and early clinical studies include: Modulation of immune cell function : GLP-1 receptor activation may reduce pro-inflammatory cytokine production from macrophages and other immune cells Reduction of oxidative stress : These medications may decrease reactive oxygen species production, which contributes to inflammatory processes Endothelial protection : GLP-1 receptor agonists may improve endothelial function and reduce vascular inflammation Inhibition of inflammatory signalling pathways : Including suppression of nuclear factor-kappa B (NF-B), a key regulator of inflammatory gene expression It's important to note that many of these mechanisms have been primarily demonstrated in laboratory or animal studies, with more limited evidence in humans

Clinical trials consistently show the best results when these medications are combined with: A calorie-conscious, nutrient-dense eating pattern our 21-Day Anti-Inflammatory Diet Plan pairs well with GLP-1 therapy Regular physical activity especially resistance training to preserve muscle mass during weight loss Consistent follow-up with your prescribing healthcare provider What About Oral Alternatives
10.1021/jacs.7b08584 J
Why understanding tirzepatide duration matters for long-term success The difference between people who succeed long-term on tirzepatide and those who struggle often comes down to understanding what the drug is actually doing inside their body, and how long it keeps doing it
Our experienced team will guide you through the process, from initial consultation to ongoing monitoring, ensuring that the treatment aligns with your health goals and medical history
doi: 10.1186/s12967-025-07224-5 137 TrangKTGulickDATruellJTianJBodkheRHiseniPet al